Procurement Summary
Country: Brazil
Summary: Price Registration Request for the Eventual Acquisition of Non-Standard Drugs, to Comply with Court Decisions, According to Specifications and Quantities Contained in Annex i of Edit...
Deadline: 03 Aug 2023
Other Information
Notice Type: Tender
TOT Ref.No.: 86169457
Document Ref. No.: 231/2023
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Purpose: Electronic Auction - Request for Price Registration for the eventual acquisition of non-standard drugs, to comply with court decisions, according to specifications and quantities contained in Annex I of the Public Notice.12:00 pm and from 1:00 pm to 5:59 pm
Submission of the Proposal: from 07/24/2023 at 08:00 am
FLUNITRAZEPAM, DOSAGE 1 MG
Quantity: 3240
GLYCOSAMINE, COMPOSITION ASSOCIATED WITH CHONDROITIN, IN SULPHATE SALTS, CONCENTRATION 1.5 G 1.2 G, PHARMACEUTICAL FORM ORAL POWDER
Amount : 2160
MEDICINAL ExTRACT, PRIACTIVE SUBSTANCE GLYCINE MAx (L.) MERRIL, CONCENTRATION 150 MG
Amount : 2160
ILOPROST, CONCENTRATION 10 MCG/ML, PHARMACEUTICAL FORM SOLUTION FOR NEBULIZATION
Amount : 33696
ILOPROST, CONCENTRATION 10 MCG/ML, PHARMACEUTICAL FORM SOLUTION FOR NEBULIZATION
Quantity : age : 11232
ISAVUCONAZONIO, CONCENTRATION 100MG
Amount : 1620
ISAVUCONAZONIUM, CONCENTRATION 100 MG
Amount : 540
LENVATINIB, CONCENTRATION 10 MG
Amount : 1620
LENVATINIB, CONCENTRATION 10 MG
Amount : 540
LENVATINIB, CONCENTRATION 4 MG
Amount : 810
LENVATINIB, CONCENTRATION 4 MG
Amount : 270
LEUPRORELIN ACETATE, CONCENTRATION 3.75 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION
Amount : 36
LEVODOPA, COMPOSITION ASSOCIATED TO BENSERAZIDE, DOSAGE 100MG 25MG, DISPERSIBLE TABLETS PRESENTATION
Quantity : 10800
LEVOTHYROxINE SODIUM, DOSAGE 112 MCG
Amount : 1080
MACROGOL, ACTIVE INGREDIENT MACROGOL 3350, COMPOSITION OF SODIUM BICARBONATE, SODIUM AND POTASSIUM CHLORIDES, CONCENTRATION 13.125 G 177.5 MG 46.6 MG 350.7 MG, PHARMACEUTICAL FORM POWDER FOR ExTEMPORARY PREPARATION
Amount : 1080
MEPOLIZUMAB, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJETABLE TICA
Quantity: 108
MEPOLIZUMAB, CONCENTRATION 100 MG/ML, INJECTABLE PHARMACEUTICAL FORM
Quantity : 36br...
Documents
Tender Notice